Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Thin Film Drug Manufacturing Market Size, Value And Growth Trends Through 2030
Strong recent growth has characterized the thin film drug manufacturing market, with its size rising from $8.71 billion in 2025 to a projected $9.51 billion in 2026, representing a compound annual growth rate (CAGR) of 9.2%. This historical expansion has been driven by factors including challenges associated with swallowing conventional tablets, an increased emphasis on improving patient compliance, the early integration of oral dissolving technologies, a growing need for therapies with rapid onset, and the broader distribution of products through hospital pharmacies.
The thin film drug manufacturing market is projected to experience robust expansion in the coming years, reaching a valuation of $13.35 billion by 2030, with a compound annual growth rate (CAGR) of 8.9%. This forecasted growth is driven by progress in thin film formulation technologies, a rising incidence of neurological disorders, the growth of e-commerce pharmaceutical sales, heightened investment in innovative drug delivery systems, and an increase in regulatory clearances for thin film medications. Key developments shaping this period include a greater embrace of oral thin films for swift medication delivery, a heightened preference for patient-convenient dosage forms, expanded use of thin films for neurological and central nervous system conditions, advances in taste-masked and orodispersible film technologies, and a growing role for thin films in managing migraines and opioid dependence.
Download A Free Sample Report For Comprehensive Market Insights:
Thin Film Drug Manufacturing Market Industry Drivers: What Is Driving Revenue Growth?
The expansion of the global elderly demographic is anticipated to drive forward the thin-film drug manufacturing market. This demographic growth is driven by factors such as longer lifespans, progress in medical science, improved nutritional standards and healthcare access, alongside evolving family dynamics and cultural norms. Thin-film drug development caters to this aging population by facilitating greater medication adherence, user-friendliness, accurate dosing, quick disintegration, and improved product stability—attributes that contribute to more effective management of chronic illnesses and overall wellness among seniors. As an example, data from the Population Reference Bureau, a U.S.-based nonprofit organization, indicates in January 2024 that the count of Americans aged 65 and above is expected to rise from 58 million in 2022 to 82 million by 2050. Consequently, the growing global elderly population serves as a key driver for the thin-film drug manufacturing industry.
Thin Film Drug Manufacturing Market Segment Analysis Highlighting Growth Areas
The thin film drug manufacturing market covered in this report is segmented –
1) By Type: Oral Thin Film, Transdermal Film, Other Types
2) By Disease Indication: Schizophrenia, Migraine, Opioid Dependence, Nausea And Vomiting, Other Disease Indications
3) By Distribution Channel: Hospital Pharmacies, Drug Stores, Retail Pharmacies, E-Commerce
Subsegments:
1) By Oral Thin Film: SubLingual Films, Buccal Films, Orodispersible Films, Taste-Masked Oral Films
2) By Transdermal Film: Adhesive Transdermal Films, Matrix Transdermal Films, Reservoir Transdermal Films, Drug-Eluting Transdermal Films
3) By Other Types: Topical Films, Ophthalmic Films, Intranasal Films, Veterinary Thin Films
Thin Film Drug Manufacturing Market Growth Trends: What Is Influencing The Future Outlook?
Leading companies in the thin film drug manufacturing sector are placing significant emphasis on creating groundbreaking products like oral thin film technologies, designed to boost patient adherence and simplify administration. These oral thin film technologies involve the development of quick-dissolving films that enable medication delivery through the oral mucous membranes, ensuring swift absorption. Such films present a practical, effective, and convenient option compared to conventional oral dosage forms, including tablets and capsules. For example, in April 2023, IntelGenx Corporation, a pharmaceutical firm from Canada, secured Food and Drug Administration (FDA) approval for RIZAFILM, a treatment aimed at acute migraine. This novel formulation dissolves and absorbs quickly, potentially offering faster migraine relief than traditional tablet forms. The advancement not only improves bioavailability but also delivers a more user-friendly and convenient choice, thereby enhancing patient compliance. By leveraging thin film technology, patient compliance and ease of use are improved, providing a more accessible alternative for handling acute migraine episodes.
Thin Film Drug Manufacturing Market Leading Companies: Who Holds Significant Market Presence?
Major companies operating in the thin film drug manufacturing market are Novartis AG, Merck KGaA, Dr. Reddy’s Laboratories, Indivior PLC, LTS Lohmann Therapie-Systeme AG, Aquestive Therapeutics, Zim Laboratories Ltd, Tapemark, AdhexPharma, MonoSol Rx, Aavishkar Oral Strips Pvt Ltd., APR Applied Pharma Research SA, Cynapsus Therapeutics Inc., Jurata Thin Film Inc., Nova Thin Film Pharmaceuticals LLC, Vektor Pharma TF GmbH, TFF Pharmaceuticals Inc., NAL Pharma, IntelGenx Corp, D.K. Livkon Healthcare Pvt Ltd.
Access The Complete Thin Film Drug Manufacturing Market Report:
Thin Film Drug Manufacturing Market Regional Analysis: Which Region Leads By Revenue?
North America was the largest region in the thin film drug manufacturing market in 2025. The regions covered in the thin film drug manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model